Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Harvard Business School
AstraZeneca
Merck
Express Scripts

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Cadazolid


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Cadazolid?

Cadazolid is an investigational drug.

There have been 5 clinical trials for Cadazolid. The most recent clinical trial was a Phase 3 trial, which was initiated on March 27th 2014.

The most common disease conditions in clinical trials are Clostridium Infections, Diarrhea, and Communicable Diseases. The leading clinical trial sponsors are Actelion and [disabled in preview].

There are sixteen US patents protecting this investigational drug and one hundred and ninety-six international patents.

Recent Clinical Trials for Cadazolid
TitleSponsorPhase
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)ActelionPhase 2/Phase 3
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated DiarrheaActelionPhase 3
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated DiarrheaActelionPhase 3

See all Cadazolid clinical trials

Clinical Trial Summary for Cadazolid

Top disease conditions for Cadazolid
Top clinical trial sponsors for Cadazolid

See all Cadazolid clinical trials

US Patents for Cadazolid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cadazolid ⤷  Try it Free Crystalline forms of cadazolid ⤷  Try it Free
Cadazolid ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
Cadazolid ⤷  Try it Free Compounds and methods of treating infections NEOCULI PTY LTD (Victoria, AU) ⤷  Try it Free
Cadazolid ⤷  Try it Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cadazolid

Drugname Country Document Number Estimated Expiration Related US Patent
Cadazolid Australia AU2017261372 2036-05-05 ⤷  Try it Free
Cadazolid Canada CA3023278 2036-05-05 ⤷  Try it Free
Cadazolid China CN107847398 2036-05-05 ⤷  Try it Free
Cadazolid European Patent Office EP3452003 2036-05-05 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Harvard Business School
AstraZeneca
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.